All In Biotech

Drug Trial Radar · NCT03062644

Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2.

A Randomized, Double-Blind, Multicenter, Placebo- and Active Comparator-Controlled Study to Evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Abdominal Hysterectomy Surgery Under General Anaesthesia (STARDOM2).

Last checked: Nov 19, 2026Latest source record: Sep 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,138 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,138

Actual

Start

Apr 5, 2017

Primary completion

Jun 29, 2018

Study completion Jun 29, 2018

Sponsor

Sponsor type
Industry
First posted
Feb 23, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The MR308-3502 study is a multicenter double-blind, randomised, placebo- and active comparator-controlled study in female subjects to evaluate the efficacy and safety of MR308 with acute pain after TAH or STAH (total or subtotal abdominal hysterectomy).

Conditions

  • Acute Pain

Interventions

  • MR308Drug

    two times daily; Mode of Administration:oral

  • MR308Drug

    four times daily; Mode of Administration:oral

  • MR308Drug

    two times daily; Mode of Administration:oral

  • MR308Drug

    given four times daily to maintain the blind; Mode of Administration:oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of MR308 doses in the treatment of moderate to severe acute pain, based on the Sum of Pain Intensity Differences (SPID) from 0-4 hours.Time frame: 0-4 hours

Locations

8 sites in 8 countries. Site status is shown where the registry gives one.

  • Minsk City Gynecology Hospital Department of Gynecology

    Minsk, Belarus

  • "Multiprofile Hospital for Active Treatment - Doverie" AD, Sofia Department of Gynecology

    Sofia, Bulgaria

  • Victoria Hospital - London Health Sciences Centre

    London, Ontario, Canada

  • Bajcsy-Zsilinszky Korhaz Szuleszet-Nogyogyaszati Osztaly

    Budapest, Hungary

  • Vidzeme Hospital Department of Gynecology and Obstetrics

    Valmiera, Latvia

  • Wojewódzki Szpital im. Św. Ojca Pio w Przemyślu Oddział Ginekologii i Położnictwa

    Przemyśl, Poland

  • Federal State Budgetary Institution National Medical-Surgical Centre named after N.I. Pirogov of the Ministry of Health of the Russian Federation Anesthesiology

    Moscow, Russia

  • Hospital Universitari Germans Trias i Pujol Anestesia y Reanimación

    Barcelona, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.